Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TNFAIP3 Gene Expression in Ankylosing Spondylitis and Psoriatic Arthritis Patients and Its Relation to Disease Activity

NCT07507487 is registered in ClinicalTrials.gov with Asmaa Hassan mohamed Abdel Mawjoud as lead sponsor.

NCT NCT07507487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07507487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TNFAIP3 Gene Expression in Ankylosing Spondylitis and Psoriatic Arthritis Patients and Its Relation to Disease Activity
Lead sponsor
Asmaa Hassan mohamed Abdel Mawjoud
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
July 31, 2029
Enrollment
110 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis and psoriatic arthritis patients